Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $12.6800 (-1.78%) ($12.6700 - $12.9600) on Mon. Jul. 31, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.33% (three month average) | RSI | 46 | Latest Price | $12.6800(-1.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.4% a day on average for past five trading days. | Weekly Trend | HALO declines -0.3% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(55%) IWO(54%) XBI(52%) IWM(49%) ARKG(48%) | Factors Impacting HALO price | HALO will decline at least -1.165% in a week (0% probabilities). VIXM(-13%) UUP(-11%) TLT(-6%) SHY(-4%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.165% (StdDev 2.33%) | Hourly BBV | 0 () | Intraday Trend | -1.8% | | | |
|
Resistance Level | $13.14 | 5 Day Moving Average | $13.11(-3.28%) | 10 Day Moving Average | $13.2(-3.94%) | 20 Day Moving Average | $13.14(-3.5%) | To recent high | -14.8% | To recent low | 7.5% | Market Cap | $1.733b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |